Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population
- PMID: 17003923
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population
Abstract
Evolvement and progression of cardiovascular diseases affecting the venous and arterial system are influenced by a multitude of environmental and hereditary factors. Many of these hereditary factors consist of defined gene polymorphisms, such as single nucleotide polymorphisms (SNPs) or insertion-deletion polymorphisms, which directly or indirectly affect the hemostatic system. The frequencies of individual hemostatic gene polymorphisms in different normal populations are well defined. However, descriptions of patterns of genetic variability of a larger extent of different factors of hereditary hypercoagulability in single populations are scarce. The aim of this study was i) to give a detailed description of the frequencies of factors of hereditary thrombophilia and their combinations in a German population (n = 282) and ii) to compare their distributions with those reported for other regions. Variants of coagulation factors [factor V 1691G>A (factor V Leiden), factor V 4070A>G (factor V HR2 haplotype), factor VII Arg353Gln, factor XIII Val34Leu, beta-fibrinogen -455G>A, prothrombin 20210G>A], coagulation inhibitors [tissue factor pathway inhibitor 536C>T, thrombomodulin 127G>A], fibrinolytic factors [angiotensin converting enzyme intron 16 insertion/deletion, factor VII-activating protease 1601G>A (FSAP Marburg I), plasminogen activator inhibitor 1-675 insertion/deletion (5G/4G), tissue plasminogen activator intron h deletion/insertion], and other factors implicated in influencing susceptibility to thromboembolic diseases [apolipoprotein E2/E3/E4, glycoprotein Ia 807C>T, methylenetetrahydrofolate reductase 677C>T] were included. The distribution of glycoprotein Ia 807C>T deviated significantly from the Hardy-Weinberg equilibrium, and a comparison with previously published data indicates marked region and ethnicity dependent differences in the genotype distributions of some other factors.
Similar articles
-
Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.Int Angiol. 2002 Dec;21(4):322-9. Int Angiol. 2002. PMID: 12518110
-
The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results.Saudi Med J. 2009 Oct;30(10):1286-90. Saudi Med J. 2009. PMID: 19838435
-
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.Am Heart J. 2003 Jan;145(1):118-24. doi: 10.1067/mhj.2003.29. Am Heart J. 2003. PMID: 12514663 Clinical Trial.
-
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.Blood. 2000 Mar 1;95(5):1517-32. Blood. 2000. PMID: 10688804 Review. No abstract available.
-
MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.Coll Antropol. 2007 Sep;31(3):919-21. Coll Antropol. 2007. PMID: 18041407 Review.
Cited by
-
VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.Cells. 2019 Nov 6;8(11):1396. doi: 10.3390/cells8111396. Cells. 2019. PMID: 31698750 Free PMC article.
-
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.Front Oncol. 2015 Jul 21;5:164. doi: 10.3389/fonc.2015.00164. eCollection 2015. Front Oncol. 2015. PMID: 26258071 Free PMC article.
-
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality.Stroke Res Treat. 2011;2011:424759. doi: 10.4061/2011/424759. Epub 2011 Jun 30. Stroke Res Treat. 2011. PMID: 21789270 Free PMC article.
-
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.Balkan J Med Genet. 2017 Jun 30;20(1):35-42. doi: 10.1515/bjmg-2017-0005. eCollection 2017 Jun 30. Balkan J Med Genet. 2017. PMID: 28924539 Free PMC article.
-
The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.J Clin Endocrinol Metab. 2016 Mar 1;10(3):1098-1103. doi: 10.1210/jc.2015-3928. Epub 2015 Dec 21. J Clin Endocrinol Metab. 2016. PMID: 26691890 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous